Skip to content

Study · Case report or series · n = 2 · 2006

1 result

Relief of acute migraine headache with intravenous oxytocin: report of two cases.

Phillips WJ, Ostrovsky O, Galli RL, Dickey S

Journal of pain & palliative care pharmacotherapy1 Jan 2006Cited by 27 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In one adult and one child with acute migraine, intravenous oxytocin promptly relieved the headache, and relief was rapid and temporally related to administration.

    In plain wordsIn two people (one adult, one child), a migraine eased quickly after oxytocin was given into a vein.

    Peptide
    Oxytocin
    Outcome
    DecreaseRelief of acute migraine headache
    Study

    n = 2

    Outcome group
    Pain · Nervous system and cognition
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Source sentences

    Summary
    We present 2 cases, one adult and one pediatric, of acute migraine headache promptly relieved by intravenous oxytocin.
    1 context sentence
    Summary · context
    Pain relief in both cases was rapid and temporally related to oxytocin administration.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.